However, in subjects with familial hypercholesterolemia, including those with a gain of function mutation in PCSK9, epidemiological studies have shown a lower DM prevalence34.Thus, the underlying mechanism explaining the relationship between PCSK9 concentration and poor glycemic control remains to be clarified. This evidence concerns the gene PCSK9 and familial hypercholesterolemia.